3B BlackBio Dx Limited
Exhibitors
Information
3B BlackBio Dx Limited (3BDx) is a leading molecular diagnostics (MDx) company specializing in the design, development, and manufacturing of advanced diagnostic solutions, including qPCR tests, Rapid Diagnostic tests, and Next-Generation Sequencing (NGS)-based kits. With over 120 products across infectious diseases and oncology, we ensure reliable and precise testing for diverse healthcare needs.
Headquartered in India, 3BDx is ISO 13485:2016 certified, GMP-compliant, and licensed by the CDSCO, Govt. of India. As a trusted name in diagnostics, we offer the largest range of Indian In Vitro Diagnostics (IVD) and CE-IVD assays.
Innovative Product Lines
1) TRUPCR®: Our flagship brand features both singlex and multiplexing RT-PCR assays for applications in cancer diagnosis, infectious diseases, human genetics, and antimicrobial resistance (AMR) targets. TRUPCR®'s comprehensive syndromic testing panels support the diagnosis of respiratory, gastrointestinal, and other infectious diseases, providing tailored solutions to diverse healthcare settings.
2) TRUNGS®: Our NGS vertical includes the TRUNGS® Solid Tumor Panel, a state-of-the-art solution for detecting SNVs, Indels, CNVs, and RNA fusions across 35 marker genes and hotspots in six pharmacogenomics genes associated with solid tumors. Expanding this portfolio, we will be introducing PAN-MYELOID NGS Panel (236 genes), BRCA Plus Kit, Endometrial Cancer Panel Kit.
3) TRURAPID®: Our rapid diagnostic tests (Lateral Flow) provide immediate, accurate point-of-care results. We are proud to announce the successful R&D completion of the TRURAPID® RESIST-5 OKNVI Rapid Test, designed to detect resistance in Carbapenems, addressing critical challenges in antimicrobial resistance (AMR).
Global Impact
As the only Indian MDx company with a UK subsidiary—TRUPCR Europe Limited—3BDx holds ISO 13485 certification by BSI, UK. We achieved U.S. FDA Emergency Use Authorization (EUA) in 2020 for COVID RT-PCR and supplied over 17 million COVID-19 RT-PCR tests across India during the pandemic.
With a presence in over 60 countries spanning the Middle East, APAC, Europe, USA, LATAM, Australia, and Africa, we are rapidly expanding our global footprint.
A Commitment to Excellence
3BDx integrates qPCR, Rapid Diagnostics, and NGS platforms under its trusted trademarks—TRUPCR®, TRUNGS®, and TRURAPID®—to provide innovative, high-quality diagnostic solutions. Driven by relentless innovation and a dedication to quality, we are transforming molecular diagnostics to improve global healthcare outcomes.
